Lupus is a chronic autoimmune disease in which the immune system mistakenly attacks healthy tissue throughout the body. The most common form, systemic lupus erythematosus (SLE), can affect the skin, joints, kidneys, brain, heart, and lungs. Nine out of every ten people diagnosed with lupus are women, and symptoms often appear between the ages of 15 and 45.
How Lupus Works in the Body
Normally, your immune system produces antibodies that target bacteria, viruses, and other invaders. In lupus, the system malfunctions and creates “autoantibodies” that recognize your own cells as foreign. These autoantibodies target proteins inside your cell nuclei, forming clumps called immune complexes. Those complexes deposit in tissues throughout the body, triggering inflammation and damage wherever they land.
Several breakdowns drive this process. The body’s cleanup system for dead and dying cells stops working properly, allowing cellular debris to accumulate. That debris exposes internal cell components the immune system doesn’t normally see, and it begins treating them as threats. At the same time, the regulatory cells that normally keep immune responses in check lose their ability to apply the brakes. The result is a self-reinforcing cycle: inflammation generates more cell damage, which generates more debris, which triggers more inflammation.
Four Types of Lupus
When people say “lupus,” they usually mean systemic lupus erythematosus, but there are actually four recognized types.
- Systemic lupus erythematosus (SLE) is the most common and most serious form. It can affect multiple organs, especially the skin, joints, and kidneys.
- Cutaneous lupus is limited to the skin. The chronic form, called discoid lupus, produces scaly patches on the face, neck, and scalp that can expand slowly, leave discolored scars, and cause permanent hair loss.
- Drug-induced lupus develops as a side effect of certain prescription medications. It mimics SLE with joint pain and lung inflammation but typically resolves once the medication is stopped.
- Neonatal lupus is rare and affects newborns of mothers who carry specific antibodies. The baby may be born with a skin rash, liver problems, or low blood cell counts, and the antibodies can affect the baby’s heart rhythm.
Which Organs Lupus Affects
SLE is called “systemic” because it can reach virtually any organ. The joints and skin are the most commonly involved. Joint pain and swelling, often in the hands and wrists, are among the earliest symptoms for most people. The classic butterfly-shaped rash across the cheeks and nose is one of the most recognizable signs, though not everyone develops it.
Kidney involvement, called lupus nephritis, is one of the more serious complications. When immune complexes deposit in the kidneys, they interfere with filtering, leading to protein in the urine and, if untreated, progressive kidney damage. In the classification system doctors use, kidney involvement carries the highest weight when evaluating disease severity.
Roughly one-third to one-half of people with SLE experience neurological or psychiatric symptoms at some point. These can range from persistent headaches, brain fog, and difficulty concentrating to more severe problems like seizures, psychosis, or stroke. Depression and anxiety are also significantly more common. Neuropsychiatric involvement is linked to a lower quality of life and, in some cases, higher mortality than lupus without these symptoms.
The lining around the heart and lungs can also become inflamed, causing chest pain and fluid buildup. Blood abnormalities are common too: low white blood cell counts, low platelet counts, and a form of anemia where the immune system destroys red blood cells.
Who Gets Lupus
Lupus disproportionately affects women, who make up about 90% of cases. It also strikes certain ethnic groups harder. Black and American Indian/Alaska Native women are two to three times more likely than white women to develop lupus. Hispanic and Asian populations are also affected at higher rates than white populations. The reasons involve a combination of genetic susceptibility, hormonal factors, and differences in immune system regulation.
How Lupus Is Diagnosed
There is no single test that confirms lupus. Diagnosis relies on a combination of symptoms, physical examination findings, and blood work. The process often takes time because lupus symptoms overlap with many other conditions and can develop gradually over months or years.
The first screening step is typically an antinuclear antibody (ANA) test. Almost all people with lupus test strongly positive for ANA, but a positive result alone doesn’t confirm the disease. About 10% of people without any autoimmune condition also test positive, usually at lower levels. An ANA titer of 1:80 or higher is considered the entry point for further evaluation.
More specific antibody tests help narrow the diagnosis. The anti-double-stranded DNA (anti-dsDNA) test is positive in about 80% of people with active, untreated lupus and at high levels is almost exclusively found in lupus patients. This antibody rises and falls with disease activity, making it useful for tracking flares. The anti-Smith antibody is another lupus-specific marker, most often found in patients who don’t have anti-dsDNA. Unlike anti-dsDNA, its levels stay constant regardless of disease activity.
Doctors also check complement proteins, which are part of the immune system’s defense chain. In lupus, these proteins get consumed as they respond to the constant immune activation, so low levels suggest active disease. Additional antibody panels can identify risk for specific complications. Anti-Ro and anti-La antibodies, for example, are associated with sun-sensitive rashes and a related condition that causes severe dry eyes and mouth.
The current classification system requires a positive ANA test plus a total score of 10 or more across clinical and immunologic criteria. Each symptom or lab finding is weighted differently. Kidney biopsy showing certain patterns of lupus nephritis carries the highest weight, followed by joint involvement, characteristic skin rashes, and seizures.
How Lupus Is Managed
Lupus is a lifelong condition with no cure, but treatment can control symptoms, prevent flares, and protect organs from permanent damage. The cornerstone medication for nearly all lupus patients is hydroxychloroquine, originally developed as an antimalarial drug. It works by dialing down immune system activity and has been shown to reduce flares, protect against organ damage, and improve long-term survival. Most people with lupus take it continuously.
During flares, stronger immune-suppressing medications may be added depending on which organs are affected and how severe the inflammation is. Treatment is highly individualized. Someone with joint pain and skin rashes needs a very different approach than someone with kidney inflammation or neuropsychiatric symptoms. The goal is always to use the least amount of immune suppression needed to keep the disease quiet, since these medications carry their own risks.
Lifestyle factors also play a meaningful role. Sun exposure triggers flares in many people with lupus, making sun protection essential. Stress management, adequate sleep, and regular exercise within your tolerance all help reduce flare frequency.
Long-Term Outlook
The prognosis for lupus has improved dramatically over the past several decades. Ten-year survival rates now exceed 90% for most groups: 93.2% for adult women and 90.2% for adult men in recent studies. Children diagnosed with lupus have even higher survival rates, approaching 99 to 100% at ten years. The biggest determinants of long-term outcome are kidney involvement, neuropsychiatric disease, and how consistently the condition is treated. Early diagnosis and consistent medication use are the strongest predictors of a good outcome.